Edwards deal highlights EU concerns over smaller pharma mergers, official says
Edwards’ attempted takeover of JenaValve highlights the EU watchdog’s concerns over below-threshold pharmaceutical mergers involving innovative smaller companies, senior EU competition official Inge Bernaerts said. She warned such deals may evade...To view the full article, register now.
Already a subscriber? Click here to view full article